Menu

Search

Tim Spector

Tim Spector

Tim Spector is a Professor of Genetic Epidemiology at Kings College, London & Director of the Department of Twin Research and Genetic Epidemiology at St Thomas’ Hospital, London. Professor Spector graduated from St Bartholomew’s Hospital Medical School, London. After working in General Medicine, he completed a MSc in Epidemiology, and his MD thesis at the University of London.

He founded the UK Twins Registry of 11,000 twins in 1993, which is one of the largest collections of genotype and phenotype information on twins worldwide. Its breadth of research has expanded to cover a wide range of common complex traits many of which were previously thought to be mainly due to ageing and environment. He has published over 700 research articles on common diseases and is ranked in the top 1% of world scientists.

He has written several original articles on the heritability of a wide range of diseases and traits including back pain, acne, inflammation, obesity, memory, musical ability and sexuality. He has published widely on obesity, food and nutrition. He also is interested in new areas of biology such as epigenetics and recently our gut microbiome and is director of the British Gut project

He has written several books, He is also author of - The Diet Myth: The real science behind what we eat by W&N 2015 and Identically different: Why you can change your genes, by W&N in 2012 and Your Genes Unzipped in 2003.

Why frequent dieting makes you put on weight – and what to do about it

Nov 26, 2016 03:00 am UTC| Health

People who regularly go on diets tend to lose weight initially but bounce back and even gain weight after stopping the regime. This phenomenon dubbed yo-yo dieting is associated with changes in metabolism and is one...

Eat your fibre or face the flesh-eating microbe cannibals

Nov 22, 2016 13:27 pm UTC| Health

Eat your bran even if it tastes horrible its good for you! Many of us remember this advice from decades ago. While fibre has been a good cure as a bulking agent for exciting disorders like constipation, it has a dull...

If there was a Nobel silver medal, I'd award it to Jeffrey Gordon and our gut microbes

Oct 05, 2016 12:29 pm UTC| Insights & Views Science

A hot tip for this years Nobel Prize in physiology or medicine was Jeffrey Gordon. (In case you missed it, the prize went to Yoshinori Ohsumi.) Over the past 15 years, Gordon has progressed an obscure study of boring gut...

Keen to be healthier in old age? Tend your inner garden

Jan 29, 2016 15:08 pm UTC| Health

The worlds oldest man, Yasutaro Koide recently died at the age of 112. Commentators as usual, focused on his reported secret to longevity: not smoking, drinking or overdoing it. No surprises there. But speculation on the...

GI diets don't work – gut bacteria and dark chocolate are a better bet for losing weight

Jan 11, 2016 14:50 pm UTC| Health

The GI (glycaemic index) rating score as well as its cousin the glycaemic load have been the mainstay of most of the diet regimens of the last 30 years. Famous best-selling diet books such as the G-Plan Diet, The South...

The sun goes down on Vitamin D: why I changed my mind about a celebrated supplement

Jan 11, 2016 14:50 pm UTC| Health

Everyone loves D, the sunshine vitamin. Doctors, patients and the media have been enamoured with vitamin D supplements for decades. As well as their clear benefit in curing severe vitamin D deficiencies, endless headlines...

Festive heartburn cures: why over-the-counter drugs may be hurting your gut

Dec 31, 2015 10:27 am UTC| Health

At the time of Xmas parties many of us may be waking up with regrets, sore heads, fragile stomachs and some heartburn (acid reflux) which in a year can affect over 40% of us and one in five weekly. In the past, we may...

1 

Economy

Global Markets Slide as Tech Stocks Sink, Yields Rise, and AI Concerns Deepen

Global financial markets ended Friday on a weaker note as major stock indexes declined, led by a sharp selloff in technology shares amid renewed skepticism over artificial intelligence investments. Rising U.S. Treasury...

Fed Near Neutral Signals Caution Ahead, Shifting Focus to Fixed Income in 2026

The Federal Reserves latest policy signals suggest that interest rates are now close to neutral, raising the bar for additional rate cuts in 2025 and beyond. This shift implies restraint rather than rescue from the central...

S&P 500 Slides as AI Chip Stocks Tumble, Cooling Tech Rally

U.S. stocks closed sharply lower on Friday as a selloff in technology shares, led by semiconductor companies, weighed heavily on broader markets and dampened enthusiasm around the artificial intelligence trade. The...

Fed Rate Cut Signals Balance Between Inflation and Jobs, Says Mary Daly

Federal Reserve Bank of San Francisco President Mary Daly said she supported cutting interest rates at this weeks Federal Open Market Committee (FOMC) meeting, highlighting the central banks effort to carefully balance...

Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only

Ireland has clarified that its proposed legislation to curb trade with Israeli settlements in the occupied West Bank will apply strictly to goods, not services, according to a senior minister speaking to Reuters. The...

Politics

Trump Signals Two Final Candidates for Fed Chair, Calls for Presidential Input on Interest Rates

U.S. President Donald Trump said he has narrowed his search for the next Federal Reserve chair to two leading candidates and suggested that the White House should be consulted on future interest rate decisions, a stance...

New Epstein Photos Surface Showing Trump as Lawmakers Near Document Release Deadline

Congressional Democrats have released 19 new photographs from the estate of the late Jeffrey Epstein, reigniting political debate as a deadline approaches for the release of thousands of documents related to the disgraced...

Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs

The U.S. Air Force has confirmed another delay in the delivery of the next-generation Air Force One aircraft, pushing the expected arrival of the first jet to mid-2028. This marks an additional one-year setback in a...

California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee

California and 18 other U.S. states are preparing to file a lawsuit in federal court to block President Donald Trumps proposed $100,000 fee on new H-1B visas for highly skilled foreign workers. The lawsuit, to be filed in...

Preservation Group Sues Trump Administration to Halt $300 Million White House Ballroom Project

A leading historic preservation group has filed a lawsuit against U.S. President Donald Trump and several federal agencies in an effort to block construction of a proposed $300 million ballroom at the White House site,...

Science

Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman

The U.S. Senate Commerce Committee announced it will vote on December 8 on President Donald Trumps renewed nomination of private astronaut and tech entrepreneur Jared Isaacman to lead NASA. Isaacman, known for his...

NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead

NASA has significantly scaled back Boeings Starliner program after years of technical issues and delays, announcing that the next Starliner mission to the International Space Station (ISS) will fly without astronauts. The...

Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission

Blue Origins massive New Glenn rocket marked a major milestone as it completed its first mission for paying customers, sending two NASA satellites toward Mars and successfully landing its reusable booster at sea. The...

Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment

Cogent Biosciences (NASDAQ: COGT) shares skyrocketed over 120% after the biotech company announced groundbreaking results from its Phase 3 PEAK trial evaluating bezuclastinib in combination with sunitinib for patients with...

Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage

U.S. President Donald Trump and German pharmaceutical company Merck KGaA have announced a groundbreaking deal aimed at lowering the cost of in-vitro fertilization (IVF) treatments while boosting access to fertility care in...

Technology

SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation

SpaceX, the aerospace company founded by Elon Musk, has reportedly authorized an insider share sale that places its valuation at approximately $800 billion, according to a Bloomberg News report published Friday. The move...

Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand

Mizuho Securities has raised its price target on Broadcom Inc. (NASDAQ: AVGO), highlighting accelerating momentum in the companys artificial intelligence business and a rapidly expanding long-term backlog. The brokerage...

Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform

Atlassian Corps popular work management software Trello experienced a service disruption on Friday, leaving a number of users unable to access the platform. The outage was flagged by internet monitoring service...

Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns

Intel has tested advanced chipmaking equipment this year from ACM Research, a semiconductor toolmaker with deep operational ties to China, according to sources familiar with the matter. The move has drawn scrutiny because...

Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO

Moore Threads Technology Co Ltd (SS:688795), a Chinese graphics chipmaker often described as Chinas potential rival to NVIDIA Corporation (NASDAQ:NVDA), saw its share price fall sharply on Friday after the company issued a...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.